Dr. Mukund Gurjar

Executive Director, Chief Scientific Officer of our company

Dr. Gurjar has played a vital role to help develop Emcure’s differentiated portfolio across key target therapeutic areas and establish multiple tech-driven innovative platforms.

His interest is in synthesis of complex molecules and drugs containing chiral centres. This expertise culminated in development of many chiral drugs for cardio vascular diseases, anti-inflammatory, proton-pumping inhibitors. The non-biological complex iron drugs and anti-hyperphosphatemia coupled with complex oncology drug, HIV drugs etc. form the basic premise of his applied research activities.

Dr Gurjar held membership of many journals including American Chemical Society, Taylor-Francis, Harwood Academic, and Indian Chemical Society. He is a member of many Indian Academic Societies.

Dr Mukund Gurjar holds two Ph. D. degrees from Nagpur and London Universities in Chemistry and did his Post-Doctoral Research at the York University, Toronto, Canada. Dr Gurjar retired from the distinguished CSIR-National Chemical Laboratory, Pune as a Deputy Director and Head of Chemistry Division. He has to his credit over 250 publications and over 180 patents. A large number of research scholars have secured Ph. D degrees under Dr Gurjar supervision.

The prestigious Council of Scientific and Industrial Research, New Delhi had published portfolios of 75 eminent scientists, Dr Gurjar name appeared in that list